Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-29 @ 1:25 PM
Study NCT ID:
NCT05737303
Status:
RECRUITING
Last Update Posted:
2025-02-11
First Post:
2023-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
Sponsor:
Women's Hospital School Of Medicine Zhejiang University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-02
First Submit QC Date:
None
Study First Post Date:
2023-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-09
Last Update Post Date:
2025-02-11
Last Update Post Date Type:
ACTUAL